Back to search
Rheopheresis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rheopheresis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rheopheresis trials you may qualify forCalcifying uremic arteriolopathy (or uremic calciphylaxis) is a rare disease (prevalence \<1% of dialysis patients), but the prognosis is often catastrophic. Th…
Peripheral arterial disease (PAD) with limb-threatening ischemia (PAD-LTI) involves both macrocirculation and microcirculation. Macrocirculatory abnormalities a…
Peripheral arterial disease (PAD) is common in chronic hemodialysis patients (HDC) with a prevalence of 30% according to the DOPPS study. The combination of PA…